Gufic Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve 1. Audited Financial Results ....
GUFICBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gufic Biosciences has informed the stock exchanges that its Board of Directors will meet on Friday, May 30, 2025 to consider and approve the audited financial results (standalone and consolidated) for the quarter and financial year ended March 31, 2025. The Board will also consider recommending a final dividend, if any, on equity shares for FY 2024-25, subject to shareholder approval at the upcoming Annual General Meeting. The trading window for designated persons remains closed until 48 hours after the results are declared.
This is a routine procedural intimation ahead of the Q4 and FY25 earnings announcement. Investors should watch May 30, 2025 for the actual results and any dividend declaration, which could be a near-term catalyst for the stock.